Korean Journal of Radiology

  • 제16권2호
  • /
  • Pages.314-324
  • /
  • 2015
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

The Accuracy of Ultrasonography for the Evaluation of Portal Hypertension in Patients with Cirrhosis: A Systematic Review

  • Kim, Gaeun (College of Nursing, Research Institute for Nursing Science, Keimyung University) ;
  • Cho, Youn Zoo (Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine) ;
  • Baik, Soon Koo (Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine) ;
  • Kim, Moon Young (Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine) ;
  • Hong, Won Ki (Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine) ;
  • Kwon, Sang Ok (Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine)
  • 투고 : 2014.08.01
  • 심사 : 2014.12.15
  • 발행 : 2015.04.01
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: Studies have presented conflicting results regarding the accuracy of ultrasonography (US) for diagnosing portal hypertension (PH). We sought to identify evidence in the literature regarding the accuracy of US for assessing PH in patients with liver cirrhosis. Materials and Methods: We conducted a systematic review by searching databases, including MEDLINE, EMBASE, and the Cochrane Library, for relevant studies. Results: A total of 14 studies met our inclusion criteria. The US indices were obtained in the portal vein (n = 9), hepatic artery (n = 6), hepatic vein (HV) (n = 4) and other vessels. Using hepatic venous pressure gradient (HVPG) as the reference, the sensitivity (Se) and specificity (Sp) of the portal venous indices were 69-88% and 67-75%, respectively. The correlation coefficients between HVPG and the portal venous indices were approximately 0.296-0.8. No studies assess the Se and Sp of the hepatic arterial indices. The correlation between HVPG and the hepatic arterial indices ranged from 0.01 to 0.83. The Se and Sp of the hepatic venous indices were 75.9-77.8% and 81.8-100%, respectively. In particular, the Se and Sp of HV arrival time for clinically significant PH were 92.7% and 86.7%, respectively. A statistically significant correlation between HVPG and the hepatic venous indices was observed (0.545-0.649). Conclusion: Some US indices, such as HV, exhibited an increased accuracy for diagnosing PH. These indices may be useful in clinical practice for the detection of significant PH.

키워드

참고문헌

  1. Kim MY, Baik SK. Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension. Korean J Gastroenterol 2009;54:143-148 https://doi.org/10.4166/kjg.2009.54.3.143
  2. Kim MY, Baik SK, Suk KT, Yea CJ, Lee IY, Kim JW, et al. Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea. Korean J Hepatol 2008;14:150-158 https://doi.org/10.3350/kjhep.2008.14.2.150
  3. Baik SK. Haemodynamic evaluation by Doppler ultrasonography in patients with portal hypertension: a review. Liver Int 2010;30:1403-1413 https://doi.org/10.1111/j.1478-3231.2010.02326.x
  4. Baik SK, Park DH, Kim MY, Choi YJ, Kim HS, Lee DK, et al. Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity. J Gastroenterol 2003;38:1150-1154 https://doi.org/10.1007/s00535-003-1222-8
  5. Lebrec D. Methods to evaluate portal hypertension. Gastroenterol Clin North Am 1992;21:41-59
  6. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133:481-488 https://doi.org/10.1053/j.gastro.2007.05.024
  7. Vizzutti F, Arena U, Rega L, Pinzani M. Non invasive diagnosis of portal hypertension in cirrhotic patients. Gastroenterol Clin Biol 2008;32(6 Suppl 1):80-87 https://doi.org/10.1016/S0399-8320(08)73997-6
  8. Kim MY, Suk KT, Baik SK, Kim HA, Kim YJ, Cha SH, et al. Hepatic vein arrival time as assessed by contrastenhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis. Hepatology 2012;56:1053-1062 https://doi.org/10.1002/hep.25752
  9. Schepke M, Raab P, Hoppe A, Schiedermaier P, Brensing KA, Sauerbruch T. Comparison of portal vein velocity and the hepatic venous pressure gradient in assessing the acute portal hemodynamic response to propranolol in patients with cirrhosis. Am J Gastroenterol 2000;95:2905-2909 https://doi.org/10.1111/j.1572-0241.2000.03202.x
  10. Ohnishi K, Saito M, Nakayama T, Iida S, Nomura F, Koen H, et al. Portal venous hemodynamics in chronic liver disease: effects of posture change and exercise. Radiology 1985;155:757-761 https://doi.org/10.1148/radiology.155.3.3890004
  11. Vizzutti F, Arena U, Rega L, Romanelli RG, Colagrande S, Cuofano S, et al. Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virusrelated chronic liver disease. Liver Int 2007;27:1379-1388
  12. Kim SY, Jeong WK, Kim Y, Heo JN, Kim MY, Kim TY, et al. Changing waveform during respiration on hepatic vein Doppler sonography of severe portal hypertension: comparison with the damping index. J Ultrasound Med 2011;30:455-462 https://doi.org/10.7863/jum.2011.30.4.455
  13. Kim MY, Baik SK, Park DH, Lim DW, Kim JW, Kim HS, et al. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study. Liver Int 2007;27:1103-1110 https://doi.org/10.1111/j.1478-3231.2007.01526.x
  14. Tasu JP, Rocher L, PEletier G, Kuoch V, Kulh E, Miquel A, et al. Hepatic venous pressure gradients measured by duplex ultrasound. Clin Radiol 2002;57:746-752 https://doi.org/10.1053/crad.2002.0951
  15. Schneider AW, Kalk JF, Klein CP. Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure. J Hepatol 1999;30:876-881
  16. Taourel P, Blanc P, Dauzat M, Chabre M, Pradel J, Gallix B, et al. Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure. Hepatology 1998;28:932-936 https://doi.org/10.1002/hep.510280406
  17. Baik SK, Kim JW, Kim HS, Kwon SO, Kim YJ, Park JW, et al. Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology 2006;240:574-580 https://doi.org/10.1148/radiol.2402051142
  18. Bolognesi M, Sacerdoti D, Merkel C, Bombonato G, Gatta A. Noninvasive grading of the severity of portal hypertension in cirrhotic patients by echo-color-Doppler. Ultrasound Med Biol 2001;27:901-907 https://doi.org/10.1016/S0301-5629(01)00370-2
  19. Merkel C, Sacerdoti D, Bolognesi M, Bombonato G, Gatta A. Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment. J Hepatol 1998;28:622-630 https://doi.org/10.1016/S0168-8278(98)80286-9
  20. Berzigotti A, Rossi V, Tiani C, Pierpaoli L, Zappoli P, Riili A, et al. Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension. J Gastroenterol 2011;46:687-695 https://doi.org/10.1007/s00535-010-0360-z
  21. Berzigotti A, Casadei A, Magalotti D, Castaldini N, Losinno F, Rossi C, et al. Renovascular impedance correlates with portal pressure in patients with liver cirrhosis. Radiology 2006;240:581-586 https://doi.org/10.1148/radiol.2401050585
  22. Berzigotti A, Reverter E, Garcia-Criado A, Abraldes JG, Cerini F, Garcia-Pagan JC, et al. Reliability of the estimation of total hepatic blood flow by Doppler ultrasound in patients with cirrhotic portal hypertension. J Hepatol 2013;59:717-722 https://doi.org/10.1016/j.jhep.2013.04.037
  23. Ozdogan O, Atalay H, Cimsit C, Tahan V, Tokay S, Giral A, et al. Role of echo Doppler ultrasonography in the evaluation of postprandial hyperemia in cirrhotic patients. World J Gastroenterol 2008;14:260-264 https://doi.org/10.3748/wjg.14.260
  24. Choi YJ, Baik SK, Park DH, Kim MY, Kim HS, Lee DK, et al. Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis. J Gastroenterol Hepatol 2003;18:424-429 https://doi.org/10.1046/j.1440-1746.2003.02992.x
  25. Kim MY, Jeong WK, Baik SK. Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol 2014;20:4300-4315 https://doi.org/10.3748/wjg.v20.i15.4300
  26. Kim MY, Choi H, Baik SK, Yea CJ, Won CS, Byun JW, et al. Portal hypertensive gastropathy: correlation with portal hypertension and prognosis in cirrhosis. Dig Dis Sci 2010;55:3561-3567 https://doi.org/10.1007/s10620-010-1221-6
  27. Baik SK, Jeong PH, Ji SW, Yoo BS, Kim HS, Lee DK, et al. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison. Am J Gastroenterol 2005;100:631-635 https://doi.org/10.1111/j.1572-0241.2005.41381.x
  28. Bosch J, Abraldes JG, Berzigotti A, Garcia-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009;6:573-582 https://doi.org/10.1038/nrgastro.2009.149
  29. D‘Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217-231 https://doi.org/10.1016/j.jhep.2005.10.013
  30. Kayacetin E, Efe D, Dogan C. Portal and splenic hemodynamics in cirrhotic patients: relationship between esophageal variceal bleeding and the severity of hepatic failure. J Gastroenterol 2004;39:661-667 https://doi.org/10.1007/s00535-003-1362-x
  31. Bolondi L, Gaiani S, Barbara L. Accuracy and reproducibility of portal flow measurement by Doppler US. J Hepatol 1991;13:269-273 https://doi.org/10.1016/0168-8278(91)90067-L
  32. Zoli M, Marchesini G, Brunori A, Cordiani MR, Pisi E. Portal venous flow in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis. Hepatology 1986;6:1248-1251 https://doi.org/10.1002/hep.1840060604
  33. Sato S, Ohnishi K, Sugita S, Okuda K. Splenic artery and superior mesenteric artery blood flow: nonsurgical Doppler US measurement in healthy subjects and patients with chronic liver disease. Radiology 1987;164:347-352 https://doi.org/10.1148/radiology.164.2.2955448
  34. Sacerdoti D, Gaiani S, Buonamico P, Merkel C, Zoli M, Bolondi L, et al. Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirrhosis. J Hepatol 1997;27:986-992 https://doi.org/10.1016/S0168-8278(97)80141-9
  35. Lim AK, Taylor-Robinson SD, Patel N, Eckersley RJ, Goldin RD, Hamilton G, et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 2005;54:128-133 https://doi.org/10.1136/gut.2003.030965
  36. Grier S, Lim AK, Patel N, Cobbold JF, Thomas HC, Cox IJ, et al. Role of microbubble ultrasound contrast agents in the non-invasive assessment of chronic hepatitis C-related liver disease. World J Gastroenterol 2006;12:3461-3465 https://doi.org/10.3748/wjg.v12.i22.3461
  37. Moon KM, Kim G, Baik SK, Choi E, Kim MY, Kim HA, et al. Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis. Clin Mol Hepatol 2013;19:389-398 https://doi.org/10.3350/cmh.2013.19.4.389

피인용 문헌

  1. Renin-angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review vol.10, pp.5, 2016, https://doi.org/10.1007/s12072-016-9705-x
  2. Successful Publication of Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy vol.17, pp.1, 2015, https://doi.org/10.3348/kjr.2016.17.1.5
  3. Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis vol.23, pp.1, 2015, https://doi.org/10.3350/cmh.2016.0059
  4. 1-Methyl-L-tryptophan promotes the apoptosis of hepatic stellate cells arrested by interferon-γ by increasing the expression of IFN-γRβ, IRF-1 and FAS vol.40, pp.2, 2015, https://doi.org/10.3892/ijmm.2017.3043
  5. Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis vol.11, pp.1, 2017, https://doi.org/10.5009/gnl16031
  6. To Study the Role of Duplex Sonography in Cases of Portal Hypertension vol.8, pp.52, 2015, https://doi.org/10.14260/jemds/2019/847
  7. Characterization of portal hypertension in hepatosplenic schistosoma mansoni patients using B-mode ultrasound vol.13, pp.1, 2015, https://doi.org/10.1080/16878507.2019.1702245
  8. Diagnostic accuracy of non-invasive methods detecting clinically significant portal hypertension in liver cirrhosis: a systematic review and meta-analysis vol.111, pp.3, 2015, https://doi.org/10.23736/s0026-4806.19.06143-3
  9. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literature vol.13, pp.4, 2015, https://doi.org/10.1111/jebm.12407